Cipta Sarana Medika Tbk. vs Fuji Finance Indonesia Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Fuji Finance Indonesia Tbk. trades at Rp212 (market cap 258.7B, 1.53M 24h volume). The key difference: Fuji Finance Indonesia Tbk. is the larger of the two by market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 1.53M). Which is the better fit depends on your goals.
| DKHH | FUJI | |
|---|---|---|
Market Cap | 158.12B | 258.7B |
Volume | 8.21M | 1.53M |
Lot | 82.15K | 15.34K |
Turnover | 515.2M | 315.64M |
Average Price | 62.72 | 205.76 |
Value | 515.2M | 315.64M |
Indicative Equilibrium Price | 63 | 212 |
Indicative Equilibrium Volume | 1.33K | 297 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Fuji Finance Indonesia Tbk (Company) was established first with the name of PT Jaya FajarLeasing Pratama based on Notarial Deed of Kartini Muljadi S.H., No. 287 on September 211982, which was changed to Jaya Fuji Leasing Pratama on March 28, 1983, then on July 2018 the Company's name was changed to Fuji Finance Indonesia
Read more on FUJI →